Methods of treating autism
Subjects having autism are treated with a composition that includes gamma-aminobutyric acid agonists. The gamma-aminobutyric acid agonist (GABA) can be a GABA(B) agonist, such as baclofen. The humans can be administered the GABA(B) agonist in a single dose or multiple doses.
1. A method of improving at least one of motivation, calmness, class participation, ability to tolerate stress and sleep patterns in a human having autism spectrum disorder, comprising the step of orally administering to the human a composition that includes a therapeutically effective amount of at least one GABA(B) agonist.
2. The method of claim 1 , wherein the GABA(B) agonist is administered to the human in a dose of about 0.001 mg/kg/day to about 5 mg/kg/day.
3. The method of claim 1 , wherein the GABA(B) agonist is administered to the human once a day.
4. The method of claim 1 , wherein the GABA(B) agonist is administered to the human twice a day.
5. The method of claim 1 , wherein the GABA(B) agonist is administered to the human in a dose of about 1 mg twice a day.
6. The method of claim 1 , wherein the GABA(B) agonist is administered to the human in a dose of about 10 mg three times a day.